Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramiro Ribeiro

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Retina (Philadelphia, Pa.)|August 3, 2023
CorrespondenceCaroline Baumal, Caleb Bliss, Daniel Jones, et al.
Neuroscience Letters|February 21, 2012
Artificial vision through neuronal stimulationRodrigo A Brant Fernandes, Bruno Diniz, Ramiro Ribeiro, et al.
Retina (Philadelphia, Pa.)|October 8, 2013
Drusen measurements comparison by fundus photograph manual delineation versus optical coherence tomography retinal pigment epithelial segmentation automated analysisBruno Diniz, Ramiro Ribeiro, Florian M Heussen, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 19, 2020
Novel probabilistic model of core vitreous traction using microsurgical vitrectomy toolsJawchyng L Lue, Ramiro Ribeiro, Michael J Koss, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 5, 2024
Pharmacokinetic/pharmacodynamic analysis of geographic atrophy lesion area in patients receiving pegcetacoplan treatment or shamRyan L Crass, Komal Prem, Francois Gaudreault, et al.
Scientific Reports|October 26, 2022
Association of complement C3 inhibitor pegcetacoplan with reduced photoreceptor degeneration beyond areas of geographic atrophyMaximilian Pfau, Steffen Schmitz-Valckenberg, Ramiro Ribeiro, et al.
Ophthalmology Science|January 24, 2025
Population Pharmacokinetics of Pegcetacoplan in Patients with Geographic Atrophy or Neovascular Age-related Macular DegenerationRyan L Crass, Komal Prem, Francois Gauderault, et al.
American Journal of Ophthalmology|March 6, 2021
Impact of Baseline Characteristics on Geographic Atrophy Progression in the FILLY Trial Evaluating the Complement C3 Inhibitor PegcetacoplanNathan C Steinle, Ian Pearce, Jordi Monés, et al.
Ophthalmology Science|June 5, 2023
Progression of Geographic Atrophy: Retrospective Analysis of Patients from the IRIS® Registry (Intelligent Research in Sight)Ehsan Rahimy, M Ali Khan, Allen C Ho, et al.
International Journal of Retina and Vitreous|January 8, 2025
Evaluating the reliability of a microperimetry-based method for assessing visual function in the junctional zone of geographic atrophy lesionsA Yasin Alibhai, Eric M Moult, Muhammad Usman Jamil, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Retina (Philadelphia, Pa.)|August 3, 2023
CorrespondenceCaroline Baumal, Caleb Bliss, Daniel Jones, et al.
Neuroscience Letters|February 21, 2012
Artificial vision through neuronal stimulationRodrigo A Brant Fernandes, Bruno Diniz, Ramiro Ribeiro, et al.
Retina (Philadelphia, Pa.)|October 8, 2013
Drusen measurements comparison by fundus photograph manual delineation versus optical coherence tomography retinal pigment epithelial segmentation automated analysisBruno Diniz, Ramiro Ribeiro, Florian M Heussen, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 19, 2020
Novel probabilistic model of core vitreous traction using microsurgical vitrectomy toolsJawchyng L Lue, Ramiro Ribeiro, Michael J Koss, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 5, 2024
Pharmacokinetic/pharmacodynamic analysis of geographic atrophy lesion area in patients receiving pegcetacoplan treatment or shamRyan L Crass, Komal Prem, Francois Gaudreault, et al.
Scientific Reports|October 26, 2022
Association of complement C3 inhibitor pegcetacoplan with reduced photoreceptor degeneration beyond areas of geographic atrophyMaximilian Pfau, Steffen Schmitz-Valckenberg, Ramiro Ribeiro, et al.
Ophthalmology Science|January 24, 2025
Population Pharmacokinetics of Pegcetacoplan in Patients with Geographic Atrophy or Neovascular Age-related Macular DegenerationRyan L Crass, Komal Prem, Francois Gauderault, et al.
American Journal of Ophthalmology|March 6, 2021
Impact of Baseline Characteristics on Geographic Atrophy Progression in the FILLY Trial Evaluating the Complement C3 Inhibitor PegcetacoplanNathan C Steinle, Ian Pearce, Jordi Monés, et al.
Ophthalmology Science|June 5, 2023
Progression of Geographic Atrophy: Retrospective Analysis of Patients from the IRIS® Registry (Intelligent Research in Sight)Ehsan Rahimy, M Ali Khan, Allen C Ho, et al.
International Journal of Retina and Vitreous|January 8, 2025
Evaluating the reliability of a microperimetry-based method for assessing visual function in the junctional zone of geographic atrophy lesionsA Yasin Alibhai, Eric M Moult, Muhammad Usman Jamil, et al.
Pageof 3